- IsoRay Takes Liberties With Lung Cancer Study Results to Prop Up Stock Price
- Shadow Work: How Businesses Are Turning Us All Into Unpaid Laborers
- Boomers' Biggest Retirement Regret? They Didn't Work Longer
- Carnival CEO Aims to Bust the Biggest Myths About the Cruise Industry
- The 10 Poorest States in America
An investor, a lawyer, a banker and a consultant weigh in on the effect of shareholder anger over executive compensation.
With valuations high for healthy snack companies, SkinnyPop couldn't refuse to get back on the auction block.
As Israel's Teva Pharmaceutical Industries (TEVA) unveiled its $82 per share bid for Mylan (MYL) Tuesday, the hostile takeover attempt may be a harbinger of things to come.
Insurgents are finding ways to apply pressure, especially where the nature of the ownership is depressing stock prices.
March madness has nothing on Wall Street as the first Monday in the month kicks off with several multi-billion dollar deals.
Shareholder activists are mounting campaigns at a record pace, and few are more successful and feared than these ten.
Hospital operator HCA Holdings is on the hunt for more hospitals, especially large ones, often not-for-profits.
Engaged Capital's Glenn Wellington envisions sponsors assisting in campaigns, but bemoans 'white knight' situations.
Nelson Peltz will relinquish his seat at Legg Mason after placing a lieutenant on the New York lender's expanded board.
Ad-tech company Datalogix may be getting attention from potential acquirers, sources tell The Deal's Jonathan Marino.